Aetas Pharma

Developer of therapies for treating heart and kidney diseases

placeTokyo, Tokyo, Japan calendar_todayFounded 2000 language aetaspharma.com

Innovation

9 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 227 times.

YearFilings
20142
20151
20162
20172
20181
20193
20202
20212
20221
20232
20241
20251

Investor mix

2 investors on record; lead investors include Mitsui Sumitomo Insurance Venture Capital.

Investor typeCountShare
Venture capital2100%
Coming soon